Rosemont Pharmaceuticals
Rosemont Pharmaceuticals manufactures and supplies liquid medicines.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD373m (Public information from Mar 2013)
Company register number 00924648
Leeds England (HQ & founding location)
Financials
Estimates*
GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 46.3m | 46.5m | 42.7m | 41.8m | 56.6m | 70.8m | 89.3m |
% growth | (27 %) | - | (8 %) | (2 %) | 35 % | 25 % | 26 % |
EBITDA | 24.8m | 23.4m | 21.3m | 18.2m | 24.5m | 41.9m | 38.2m |
% EBITDA margin | 53 % | 50 % | 50 % | 43 % | 43 % | 59 % | 43 % |
Profit | (114m) | 17.1m | 16.0m | 14.0m | 20.6m | 39.0m | 36.4m |
% profit margin | (246 %) | 37 % | 38 % | 34 % | 36 % | 55 % | 41 % |
Related Content
Recent News about Rosemont Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Rosemont Pharmaceuticals
EditACQUISITION by Rosemont Pharmaceuticals Jun 2023
ACQUISITION by Rosemont Pharmaceuticals Jun 2024
ACQUISITION by Rosemont Pharmaceuticals Jul 2024
ACQUISITION by Rosemont Pharmaceuticals Jul 2024
ACQUISITION by Rosemont Pharmaceuticals Jul 2024
ACQUISITION by Rosemont Pharmaceuticals Jul 2024